influenza vaccine (TLR-3 adjuvant,adenovirus vector) (Vaxart)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinfluenza vaccine (TLR-3 adjuvant,adenovirus vector) (Vaxart)

Drug Alias Nameinfluenza vaccine (West Coast Biologicals)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine

Mechanisms of ActionToll like receptor 3 agonists

TargetsToll like receptor 3

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVaxart Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVaxart Biosciences Inc

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A